Decoding the Role of DVL1 in Intracranial Meningioma

In the search for molecular candidates for targeted meningioma therapies, increasing attention has been paid to the role of signaling pathways in the development and progression of intracranial meningiomas. Although it is well known that the Wnt signaling pathway is involved in meningioma progressio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anja Bukovac, Katarina Dragičević, Anja Kafka, Darko Orešković, Sanja Cesarec-Augustinović, Nives Pećina-Šlaus
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/8d63e4e9d8984431aa78cd508119c9ee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8d63e4e9d8984431aa78cd508119c9ee
record_format dspace
spelling oai:doaj.org-article:8d63e4e9d8984431aa78cd508119c9ee2021-11-11T17:24:49ZDecoding the Role of DVL1 in Intracranial Meningioma10.3390/ijms2221119961422-00671661-6596https://doaj.org/article/8d63e4e9d8984431aa78cd508119c9ee2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11996https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067In the search for molecular candidates for targeted meningioma therapies, increasing attention has been paid to the role of signaling pathways in the development and progression of intracranial meningiomas. Although it is well known that the Wnt signaling pathway is involved in meningioma progression, the role of its central mediator, DVL1, is still unclear. In order to investigate the influence of <i>DVL1</i> gene alterations on the progression of human intracranial meningioma, we focused on its central PDZ domain, which is responsible for DVL interaction with the Fzd receptor and the phosphorylation of DVL mediated through the casein kinases CK1 and CK2. A genetic analysis of genomic instability revealed the existence of microsatellite instability in 9.09% and the loss of heterozygosity in 6.06% of the samples. The sequencing of the PDZ gene region showed repetitive deletions of two bases located in intron 7 and exon 8, and a duplication in intron 8 in most samples, with different outcomes on the biological function of the DVL1 protein. Immunohistochemistry revealed that the nuclear expression of DVL1 was significantly correlated with a higher expression of active β-catenin (<i>p</i> = 0.029) and a higher meningioma grade (<i>p</i> = 0.030), which leads to the conclusion that it could be used as biomarker for meningioma progression and the activation of the Wnt signaling pathway.Anja BukovacKatarina DragičevićAnja KafkaDarko OreškovićSanja Cesarec-AugustinovićNives Pećina-ŠlausMDPI AGarticleDVL1PDZ domainβ-cateninWnt signaling pathwayintracranial meningiomaBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11996, p 11996 (2021)
institution DOAJ
collection DOAJ
language EN
topic DVL1
PDZ domain
β-catenin
Wnt signaling pathway
intracranial meningioma
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle DVL1
PDZ domain
β-catenin
Wnt signaling pathway
intracranial meningioma
Biology (General)
QH301-705.5
Chemistry
QD1-999
Anja Bukovac
Katarina Dragičević
Anja Kafka
Darko Orešković
Sanja Cesarec-Augustinović
Nives Pećina-Šlaus
Decoding the Role of DVL1 in Intracranial Meningioma
description In the search for molecular candidates for targeted meningioma therapies, increasing attention has been paid to the role of signaling pathways in the development and progression of intracranial meningiomas. Although it is well known that the Wnt signaling pathway is involved in meningioma progression, the role of its central mediator, DVL1, is still unclear. In order to investigate the influence of <i>DVL1</i> gene alterations on the progression of human intracranial meningioma, we focused on its central PDZ domain, which is responsible for DVL interaction with the Fzd receptor and the phosphorylation of DVL mediated through the casein kinases CK1 and CK2. A genetic analysis of genomic instability revealed the existence of microsatellite instability in 9.09% and the loss of heterozygosity in 6.06% of the samples. The sequencing of the PDZ gene region showed repetitive deletions of two bases located in intron 7 and exon 8, and a duplication in intron 8 in most samples, with different outcomes on the biological function of the DVL1 protein. Immunohistochemistry revealed that the nuclear expression of DVL1 was significantly correlated with a higher expression of active β-catenin (<i>p</i> = 0.029) and a higher meningioma grade (<i>p</i> = 0.030), which leads to the conclusion that it could be used as biomarker for meningioma progression and the activation of the Wnt signaling pathway.
format article
author Anja Bukovac
Katarina Dragičević
Anja Kafka
Darko Orešković
Sanja Cesarec-Augustinović
Nives Pećina-Šlaus
author_facet Anja Bukovac
Katarina Dragičević
Anja Kafka
Darko Orešković
Sanja Cesarec-Augustinović
Nives Pećina-Šlaus
author_sort Anja Bukovac
title Decoding the Role of DVL1 in Intracranial Meningioma
title_short Decoding the Role of DVL1 in Intracranial Meningioma
title_full Decoding the Role of DVL1 in Intracranial Meningioma
title_fullStr Decoding the Role of DVL1 in Intracranial Meningioma
title_full_unstemmed Decoding the Role of DVL1 in Intracranial Meningioma
title_sort decoding the role of dvl1 in intracranial meningioma
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/8d63e4e9d8984431aa78cd508119c9ee
work_keys_str_mv AT anjabukovac decodingtheroleofdvl1inintracranialmeningioma
AT katarinadragicevic decodingtheroleofdvl1inintracranialmeningioma
AT anjakafka decodingtheroleofdvl1inintracranialmeningioma
AT darkooreskovic decodingtheroleofdvl1inintracranialmeningioma
AT sanjacesarecaugustinovic decodingtheroleofdvl1inintracranialmeningioma
AT nivespecinaslaus decodingtheroleofdvl1inintracranialmeningioma
_version_ 1718432130181103616